Quarterly report pursuant to Section 13 or 15(d)

Equity Awards (Tables)

v3.22.2.2
Equity Awards (Tables)
3 Months Ended
Aug. 31, 2022
Equity Awards  
Schedule of Warrant Liability and Equity

(in thousands)

    

Liability Classified Warrants

Balance at May 31, 2022

$

Classified as liability due to lack of shares availability at issuance

 

14,522

Classified as equity upon increase in availability

 

(23,123)

Loss on derivative due to change in fair market value

 

8,601

Balance at August 31, 2022

$

Schedule of Assumptions Used in Determination of Fair Value

    

    

Initial Fair Market Value At Issuance

    

Fair Market Value at August 31, 2022

Backstop

Backstop

Placement

Backstop

Backstop

Placement

Warrant #1

Warrant #2

Agent Warrants

Warrant #1

Warrant #2

Agent Warrants

Fair value of underlying stock

$ 0.44

$ 0.42

$ 0.44

$ 0.52

$ 0.52

$ 0.52

Risk free rate

3.17%

3.06%

3.13%

3.34%

3.31%

3.16%

Expected term (in years)

4.65

5.00

10.00

4.46

4.88

9.82

Stock price volatility

110.20%

109.49%

95.99%

117.29%

113.59%

95.87%

Expected dividend yield

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

Stock Option and Warrant Activity

Weighted 

average

Weighted

remaining

Aggregate

Number of

average

contractual

intrinsic

(in thousands, except per share data)

    

shares

    

exercise price

    

life in years

    

value

Options and warrants outstanding at May 31, 2022

 

90,705

$

0.77

 

4.06

$

352

Granted

 

104,104

$

0.25

 

 

Exercised

 

(863)

$

0.49

 

 

Forfeited, expired, and cancelled

 

(484)

$

1.57

 

 

Options and warrants outstanding at August 31, 2022

 

193,462

$

0.48

 

4.36

$

36,758

Options and warrants outstanding and exercisable at August 31, 2022

 

187,896

$

0.45

 

4.24

$

36,717